No Data Available
Hemant Surgical Industries Share Price
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | - |
| EPS - TTM(₹) | - |
| MCap(₹ Cr.) | 553.88 |
| MCap Rank | 206 |
| PB Ratio(x) | 3.91 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 446.00 |
| 52W Low(₹) | 91.00 |
| MCap/Sales | 1.22 |
| Beta(1 Month) | - |
| BV/Share(₹) | 94.68 |
Hemant Surgical Ind share price insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 112.04% outperformed its 3 year CAGR of 28.2%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.28% of its operating revenues towards interest expenses and 4.35% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Hemant Surgical Ind Share Price Update
Hemant Surgical Industries Ltd. share price moved up by 3.25% from its previous close of Rs 369.00. Hemant Surgical Industries Ltd. stock last traded price is 381.00
Share Price Value Today/Current/Last 381.00 Previous Day 369.00
Found Insights useful?
Hemant Surgical Ind Share Price Returns
| 1 Day | 3.25% |
| 1 Month | 26.37% |
| 3 Months | 47.1% |
| 1 Year | 288.78% |
| 3 Years | 128.62% |
| 5 Years | N.A. |
Hemant Surgical Ind Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Revised Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Re..
AnnouncementsAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
AnnouncementsAnnouncement under Regulation 30 (LODR)-Acquisition
AnnouncementsDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcements
Financials
Annual FY 2026 Total Revenue 237.67 Total Revenue Growth (%) 112.67 Total Expenses 213.08 Total Expenses Growth (%) 110.37 Profit after Tax (PAT) 19.19 PAT Growth (%) 138.66 Operating Profit Margin (%) 11.88 Net Profit Margin (%) 8.27 Basic EPS (₹) 15.39 InsightsBeating 3 Yr Revenue CAGR
Company's annual revenue growth of 112.04% outperformed its 3 year CAGR of 28.2%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.28% of its operating revenues towards interest expenses and 4.35% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Annual FY 2026 Total Assets 274.26 Total Assets Growth (%) 84.93 Total Liabilities 136.62 Total Liabilities Growth (%) 60.47 Total Equity 137.64 Total Equity Growth (%) 117.88 Current Ratio (x) 1.45 Total Debt to Equity (x) 0.36 Contingent Liabilities 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 Net Cash flow from Operating Activities -32.04 Net Cash used in Investing Activities -2.97 Net Cash flow from Financing Activities 69.31 Net Cash Flow 34.29 Closing Cash & Cash Equivalent 43.84 Closing Cash & Cash Equivalent Growth (%) 359.17 Total Debt/ CFO (x) -1.55 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 2.97 cr for investing activities which is an YoY decrease of 90.17%. (Source: Standalone Financials)
Annual FY 2026 Return on Equity (%) 13.94 Return on Capital Employed (%) 19.51 Return on Assets (%) 6.99 Interest Coverage Ratio (x) 9.81 Asset Turnover Ratio (x) 1.10 Price to Earnings (x) 14.79 Price to Book (x) 2.06 EV/EBITDA (x) 9.95 EBITDA Margin (%) 12.54
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Hemant Surgical Ind Top Searches
Corporate Actions
Board Meeting
Audited Results
May 11, 2026
Board Meeting
Half Yearly Results
Nov 06, 2025
General Meeting
-
Aug 28, 2025
Announced on Meeting on May 11, 2026 May 15, 2026 Audited Results Nov 06, 2025 Nov 12, 2025 Half Yearly Results Aug 01, 2025 Aug 06, 2025 Preferential issue of shares May 16, 2025 May 28, 2025 Audited Results Nov 05, 2024 Nov 13, 2024 Half Yearly Results No Data Available
No Data Available
No Data Available
No Data Available
Announced on Meeting on Aug 28, 2025 Sep 23, 2025 - Aug 11, 2025 Aug 30, 2025 - Aug 30, 2024 Sep 25, 2024 A.G.M. Aug 29, 2023 Sep 30, 2023 A.G.M.
About Hemant Surgical Ind
Industry
Key Indices Listed On
-
Address
502, 5th Floor,Ecstasy Business Park Co-Op Socteiy Limited,J.S.D. Road, Mulund West,Mumbai, Maharashtra - 400080
Executive Leadership
Hanskumar Shah
Chairman & Managing DirectorKaushik Hanskumar Shah
WholeTime Director & CFOHemant Praful Shah
Whole Time DirectorNehal Babu Karelia
Non Executive DirectorAuditors
FAQs about Hemant Surgical Ind share
- 1. What's the Hemant Surgical Ind share price today?Hemant Surgical Ind share price is Rs 381.00 as on 10 Jun, 2026, 03:40 PM IST. Hemant Surgical Ind share price is up by 3.25% based on previous share price of Rs. 360.5.
- 2. What is Hemant Surgical Ind's 52 week high / low?In last 52 weeks Hemant Surgical Ind share had a high price of Rs 446.00 and low price of Rs 91.00
- 3. What are the returns for Hemant Surgical Ind share?Return Performance of Hemant Surgical Ind Shares:
- 1 Week: Hemant Surgical Ind share price moved down by 0.29%
- 4. What's the market capitalization of Hemant Surgical Ind?Within the General sector, Hemant Surgical Ind stock has a market cap rank of 206. Hemant Surgical Ind has a market cap of Rs 553.88 Cr.
- 5. What is the PE & PB ratio of Hemant Surgical Ind?The PE ratio of Hemant Surgical Ind stands at null, while the PB ratio is 3.79.
Top Gainers
As on 03:59 PM | 10 Jun 2026Top Losers
As on 03:59 PM | 10 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.